Sunitinib adverse events in metastatic renal cell carcinoma: a meta-analysis

Author： Ibrahim Ezzeldin Kazkaz Ghieth Abouelkhair Khaled Bayer Ali Elmasri Osama

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.18, Iss.6, 2013-12, pp. : 1060-1069

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Therapeutic effects and associated adverse events of multikinase inhibitors in metastatic renal cell carcinoma: A meta-analysis

Experimental and Therapeutic Medicine, Vol. 9, Iss. 6, 2015-01 ,pp. : 2275-2280

Spandidos Publications

Access to resources Recommend Favorite

Sunitinib for metastatic renal cell carcinoma

By Mukherji Deborah Larkin James Pickering Lisa

Future Oncology, Vol. 6, Iss. 9, 2010-09 ,pp. : 1377-1385

Future Medicine

Access to resources Recommend Favorite

Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient

By Medioni Jacques Cojocarasu Oana Banu Eugeniu Cassar-Queudeville Alexia Halimi Philippe Oudard Stéphane

Targeted Oncology, Vol. 2, Iss. 3, 2007-07 ,pp. : 193-195

Springer Publishing Company

Access to resources Recommend Favorite

Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma

By Bono Petri Rautiola Juhana Utriainen Tapio Joensuu Heikki

Acta Oncologica, Vol. 50, Iss. 4, 2011-05 ,pp. : 569-573

Informa Healthcare

Access to resources Recommend Favorite

Cruciferous Vegetables Consumption and Risk of Renal Cell Carcinoma: A Meta-Analysis

By Liu Ben Mao Qiqi Wang Xiao Zhou Feng Luo Jindan Wang Chaojun Lin Yiwei Zheng Xiangyi Xie Liping

Nutrition and Cancer, Vol. 65, Iss. 5, 2013-07 ,pp. : 668-676

Routledge Ltd

Access to resources Recommend Favorite